These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6068342)

  • 21. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
    Thayer PS; Himmelfarb P; Roberts D
    Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
    [No Abstract]   [Full Text] [Related]  

  • 22. The gel-filtration behaviour of dihydrofolate reductases from culture forms of trypanosomatids.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Biochim Biophys Acta; 1969; 191(3):753-5. PubMed ID: 5363996
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice.
    Chandraprakash KS; Udupa N; Umadevi P; Pillai GK
    J Drug Target; 1993; 1(2):143-5. PubMed ID: 8069552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
    Sirotnak FM; Moccio DM; Hancock CH; Young CW
    Cancer Res; 1981 Oct; 41(10):3944-9. PubMed ID: 7285003
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
    Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
    Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative properties of three pteridine reductases.
    Chang CF; Bray T; Varughese KI; Whiteley JM
    Adv Exp Med Biol; 1999; 463():403-10. PubMed ID: 10352712
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the effect of antifolics in mouse leukemia.
    Motycka K
    Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901
    [No Abstract]   [Full Text] [Related]  

  • 28. Similar specificity of membrane transport for folate analogues and their metabolites by murine and human tumor cells: a clinically directed laboratory study.
    Moccio DM; Sirotnak FM; Samuels LL; Ahmed T; Yagoda A; DeGraw JI; Piper JR
    Cancer Res; 1984 Jan; 44(1):352-7. PubMed ID: 6690047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lectin derivatives of methotrexate and chlorambucil as chemotherapeutic agents.
    Lin JY; Li JS; Tung TC
    J Natl Cancer Inst; 1981 Mar; 66(3):523-8. PubMed ID: 6937708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gel filtration properties of mutant and wild-type dihydrofolate reductase from Diplococcus pneumoniae.
    Sirotnak FM; Hutchison DJ
    Biochem Biophys Res Commun; 1965 Jun; 19(6):734-8. PubMed ID: 4378809
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy of sarcoma 180 with methotrexate and bleomycin.
    Skeel RT; Bertino JR
    Cancer Res; 1973 May; 33(5):1028-31. PubMed ID: 4122164
    [No Abstract]   [Full Text] [Related]  

  • 32. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacologic aspects of homofolate derivatives in relation to amethopterin-resistant murine leukemia.
    Mead JA; Goldin A; Kisliuk RL; Friedkin M; Plante L; Crawford EJ; Kwok G
    Cancer Res; 1966 Nov; 26(11):2374-9. PubMed ID: 4959533
    [No Abstract]   [Full Text] [Related]  

  • 34. Activity of "early" and "late" dehydrofolate reductase in induced abnormalities of mammalian embryogenesis.
    Repin VS; Geiro ND; Rostovtsev VN; Vaisman BL
    Sov J Dev Biol; 1972; 3(1):51-7. PubMed ID: 4515020
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract]   [Full Text] [Related]  

  • 36. The binding of colchicine by sarcoma 180 cells.
    Creasey WA; Chou TC
    Biochem Pharmacol; 1968 Mar; 17(3):477-80. PubMed ID: 5661656
    [No Abstract]   [Full Text] [Related]  

  • 37. Methotrexate and folic acid effect in normal and sarcoma 180 bearing mice.
    Motycka K; Balcarová A
    Neoplasma; 1975; 22(5):507-18. PubMed ID: 1196433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous changes in various mechanisms that mediate the cell incorporation of folate compounds account for low levels of resistance to methotrexate.
    Cavalcanti F; Calvo N; Grau-Oliete MR; Rivera-Fillat MP
    Cell Biochem Funct; 1992 Mar; 10(1):1-7. PubMed ID: 1533575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases.
    Jackson RC; Hart LI; Harrap KR
    Cancer Res; 1976 Jun; 36(6):1991-7. PubMed ID: 5189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incorporation of H3-thymidine into the DNA of cells of surviving slices of transplantable tumors, sensitive and resistant to sarcolysine].
    Merkulov MF; Shelaputina ZF; Iavorskaia NP; Leskova SG
    Farmakol Toksikol; 1970; 33(6):715-23. PubMed ID: 5518494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.